26 December 2018 - President Trump was riding high in July after a series of strident tweets and personal phone calls paid off: Pfizer, a top drug manufacturer, had decided to defer price increases for the rest of the year.

He called it “great news” for American consumers, and other companies followed suit. They froze their prices while the White House worked on a prescription-pricing blueprint.

But with New Year’s Day looming, the freeze is thawing.

Read Washington Times article